Searched for
ZYDUS GROUP
Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...30 May, 2026, 11.17 PM IST- Zydus Lifesciences buyback alert! Last date to buy shares to participate in Rs 1,100 crore buyback at 7% premiumInvestors must purchase Zydus Lifesciences shares by Wednesday, May 27, to be eligible for the Rs 1,100 crore buyback, as the record date i...27 May, 2026, 01.02 PM IST
- Zydus Lifesciences' Rs 1,100 crore share buyback at 13% premium: Check record date, other detailsZydus Lifesciences is launching its largest share buyback program to date. The company plans to repurchase shares worth Rs 1,100 crore. Thi...20 May, 2026, 09.13 AM IST
- Tata group’s Impetis out-licenses arthritis and autoimmune drugs to VyomeIn a significant move for medical innovation, Impetis Biosciences, a subsidiary of Tata group, has teamed up with Vyome Holdings from the U...14 May, 2026, 01.25 AM IST
- Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...08 May, 2026, 08.54 AM IST
- Zydus Biologics’ Ahmedabad injectable facility gets 7 observations in USFDA inspectionZydus Lifesciences has made headlines as its Zydus Biologics injectable plant in Ahmedabad underwent a USFDA inspection between April 27 an...06 May, 2026, 01.25 PM IST
- Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...21 Apr, 2026, 08.37 AM IST
- Semaglutide API price plunges amid GLP-1 rushGlobal demand for weight-loss drugs Ozempic and Wegovy has caused semaglutide prices to drop significantly. Manufacturing has expanded rapi...17 Apr, 2026, 12.54 AM IST
- Mounjaro sales dip amid price war as semaglutide generics gain groundMounjaro, the star pharmaceutical from Eli Lilly, is experiencing a downturn in sales across India. This slump can be attributed to competi...10 Apr, 2026, 09.22 AM IST
- Zydus Group to invest Rs 5,000 cr in GujaratZydus Group plans to invest Rs 5,000 crore in Gujarat, including biotechnology products and hospitals. Memoranda of Understanding (MoUs) ha...12 Jan, 2024, 05.19 PM IST
- Hope to start supply of ZyCoV-D vaccine by mid to end September: Zydus Group MD"Post the emergency use authorisation, now we will work closely with the regulatory authorities to work on the pricing and modality of deli...21 Aug, 2021, 05.14 PM IST
- Maruti Suzuki sets up multi-specialty hospital at Sitapur in GujaratManaged and operated by Ramanbhai Foundation, the CSR arm of Zydus Group, the hospital is also assisting in taking care of Covid-19 patient...18 May, 2021, 05.19 PM IST
- Zydus Group clinches in-licensing deal with Swiss company Neovii"The Zydus group will market this therapy through Zydus Trans-immune, a division that offers a range of therapies related to transplant med...06 Oct, 2016, 04.05 PM IST
- Zydus group inks pact with Eczacibasi to market biotech productsThe collaboration agreement involves the import of bio-similars that are currently unavailable in Turkey, especially for the treatment of c...15 Jun, 2016, 01.47 PM IST
- Zydus ties up with US-based research centre NIAD to develop vaccineThe Group employs over 16,500 people worldwide, including over 1,600 scientists in R&D. Cadila Healthcare is part of Zydus Group.23 Apr, 2015, 01.20 PM IST
- Zydus launches diabetes treatment drug LipaglynPharmaceutical entity Zydus group on Monday said it has launched Lipaglyn, its patented new drug for treatment of diabetes.16 Sep, 2013, 04.07 PM IST
- Cadila Healthcare Q3 net dips by 4.4%, sales rise 20%Cadila Healthcare, the flagship company of Zydus group, has suffered a 4.4% drop in its third quarter net profit on account of forex losses.08 Feb, 2012, 12.07 PM IST
Load More
